MENU
+Compare
ANAB
Stock ticker: NASDAQ
AS OF
Jun 26 closing price
Price
$23.38
Change
+$0.14 (+0.60%)
Capitalization
686.92M

ANAB AnaptysBio Forecast, Technical & Fundamental Analysis

AnaptysBio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANAB with price predictions
Jun 20, 2025

ANAB's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for ANAB moved out of overbought territory on June 04, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for ANAB turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANAB broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 188 cases where ANAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.202) is normal, around the industry mean (16.744). P/E Ratio (0.000) is within average values for comparable stocks, (58.931). ANAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.272). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (6.131) is also within normal values, averaging (254.097).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANAB is expected to report earnings to rise 18.75% to -151 cents per share on August 11

AnaptysBio ANAB Stock Earnings Reports
Q2'25
Est.
$-1.52
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.90
Q3'24
Beat
by $0.56
Q2'24
Missed
by $0.67
The last earnings report on May 05 showed earnings per share of -127 cents, beating the estimate of -129 cents. With 358.22K shares outstanding, the current market capitalization sits at 686.92M.
A.I. Advisor
published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRFDX35.620.06
+0.17%
T. Rowe Price Equity Income R
GFVCX14.970.01
+0.07%
Goldman Sachs Focused Value C
MGOTX8.29N/A
N/A
Victory Munder Mid-Cap Core Growth C
IPLIX26.91-0.08
-0.30%
Voya Index Plus LargeCap Port I
CSGZX74.91-0.51
-0.68%
Columbia Seligman Global Tech Inst

ANAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with QTTB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-0.94%
QTTB - ANAB
43%
Loosely correlated
-2.82%
ADCT - ANAB
37%
Loosely correlated
-8.58%
CLRB - ANAB
37%
Loosely correlated
-20.16%
SPRY - ANAB
36%
Loosely correlated
-0.69%
ENTA - ANAB
36%
Loosely correlated
-0.69%
More